Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Description

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.

Conditions

Metastatic Breast Cancer, Lobular Breast Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.

Improving Survival for Those With Metastatic Lobular Breast Cancer Through Development of the Multi-center PLUMB Registry-a Prospective Study of LobUlar Metastatic Breast Cancer

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Condition
Metastatic Breast Cancer
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94122

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
  • 2. Age \>=18 years
  • 3. Any receptor subtype.
  • 4. Ability to understand a written informed consent document, and the willingness to sign it.
  • 1. Stage I-III breast cancer.
  • 2. Lack of lobular histology on tumor biopsy.
  • 3. Other active cancer (prior treated cancer with no current evidence of disease is allowed).

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Rita Mukhtar, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2034-02-28